Cargando…

High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone

BACKGROUND: Lymphatic filariasis elimination programs are based upon preventative chemotherapy annually in populations with prevalence more than or equal to 1%. The goal is to treat 80% of the eligible, at risk population yearly, for at least 5 years, in order to interrupt transmission and prevent c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodges, Mary H, Smith, Samuel J, Fussum, Daniel, Koroma, Joseph B, Conteh, Abdul, Sonnie, Mustapha, Sesay, Santigie, Zhang, Yaobi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018440/
https://www.ncbi.nlm.nih.gov/pubmed/21162751
http://dx.doi.org/10.1186/1756-3305-3-120
_version_ 1782196067681435648
author Hodges, Mary H
Smith, Samuel J
Fussum, Daniel
Koroma, Joseph B
Conteh, Abdul
Sonnie, Mustapha
Sesay, Santigie
Zhang, Yaobi
author_facet Hodges, Mary H
Smith, Samuel J
Fussum, Daniel
Koroma, Joseph B
Conteh, Abdul
Sonnie, Mustapha
Sesay, Santigie
Zhang, Yaobi
author_sort Hodges, Mary H
collection PubMed
description BACKGROUND: Lymphatic filariasis elimination programs are based upon preventative chemotherapy annually in populations with prevalence more than or equal to 1%. The goal is to treat 80% of the eligible, at risk population yearly, for at least 5 years, in order to interrupt transmission and prevent children from becoming infected. This level of coverage has been a challenge in urban settings. Assessing the coverage in a rapidly growing urban/non-rural setting with inadequate population data is also problematic. In Sierra Leone, a 5-day preventative chemotherapy campaign was carried out in the Western Area including the capital: Freetown. An intensive, social mobilization strategy combined traditional and modern communication channels. To aid dissemination of appropriate information Frequently Asked Questions were developed and widely circulated. The population of the Western Area has grown faster than projected by the 2004 National Census due to the post-war settlement of internally displaced persons. As a reliable denominator was not available, independent monitoring was adapted and performed "in process" to aid program performance and "end process" to assess final coverage. RESULTS: In 5 days 1,104,407 eligible persons were treated. Using the projected population from the 2004 census this figure represented coverage of 116% in the Urban Western Area and 129% in the Rural Western Area. Independent monitors interviewed a total of 9,253 persons during the 2 End Process days representing 1% of the projected population. Of these, 85.8% recalled taking both ivermectin and albendazole (Urban: 85.2%, Rural: 87.1%). No serious adverse drug reactions were reported. CONCLUSION: The paper presents the key elements of success of the social mobilization and implementation strategy and describes the independent monitoring used to estimate final coverage in this urban/non-rural setting where the current population size is uncertain. This implementation strategy and Independent Monitoring tool could be useful in similar, rapidly growing cities implementing lymphatic filariasis elimination programs.
format Text
id pubmed-3018440
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30184402011-01-11 High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone Hodges, Mary H Smith, Samuel J Fussum, Daniel Koroma, Joseph B Conteh, Abdul Sonnie, Mustapha Sesay, Santigie Zhang, Yaobi Parasit Vectors Research BACKGROUND: Lymphatic filariasis elimination programs are based upon preventative chemotherapy annually in populations with prevalence more than or equal to 1%. The goal is to treat 80% of the eligible, at risk population yearly, for at least 5 years, in order to interrupt transmission and prevent children from becoming infected. This level of coverage has been a challenge in urban settings. Assessing the coverage in a rapidly growing urban/non-rural setting with inadequate population data is also problematic. In Sierra Leone, a 5-day preventative chemotherapy campaign was carried out in the Western Area including the capital: Freetown. An intensive, social mobilization strategy combined traditional and modern communication channels. To aid dissemination of appropriate information Frequently Asked Questions were developed and widely circulated. The population of the Western Area has grown faster than projected by the 2004 National Census due to the post-war settlement of internally displaced persons. As a reliable denominator was not available, independent monitoring was adapted and performed "in process" to aid program performance and "end process" to assess final coverage. RESULTS: In 5 days 1,104,407 eligible persons were treated. Using the projected population from the 2004 census this figure represented coverage of 116% in the Urban Western Area and 129% in the Rural Western Area. Independent monitors interviewed a total of 9,253 persons during the 2 End Process days representing 1% of the projected population. Of these, 85.8% recalled taking both ivermectin and albendazole (Urban: 85.2%, Rural: 87.1%). No serious adverse drug reactions were reported. CONCLUSION: The paper presents the key elements of success of the social mobilization and implementation strategy and describes the independent monitoring used to estimate final coverage in this urban/non-rural setting where the current population size is uncertain. This implementation strategy and Independent Monitoring tool could be useful in similar, rapidly growing cities implementing lymphatic filariasis elimination programs. BioMed Central 2010-12-16 /pmc/articles/PMC3018440/ /pubmed/21162751 http://dx.doi.org/10.1186/1756-3305-3-120 Text en Copyright ©2010 Hodges et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Hodges, Mary H
Smith, Samuel J
Fussum, Daniel
Koroma, Joseph B
Conteh, Abdul
Sonnie, Mustapha
Sesay, Santigie
Zhang, Yaobi
High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone
title High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone
title_full High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone
title_fullStr High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone
title_full_unstemmed High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone
title_short High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone
title_sort high coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the western area, sierra leone
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018440/
https://www.ncbi.nlm.nih.gov/pubmed/21162751
http://dx.doi.org/10.1186/1756-3305-3-120
work_keys_str_mv AT hodgesmaryh highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone
AT smithsamuelj highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone
AT fussumdaniel highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone
AT koromajosephb highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone
AT contehabdul highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone
AT sonniemustapha highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone
AT sesaysantigie highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone
AT zhangyaobi highcoverageofmassdrugadministrationforlymphaticfilariasisinruralandnonruralsettingsinthewesternareasierraleone